While programmes such as the Rockefeller campaign were specifically ta
rgeted at a particular parasite species, the current trend is towards
the simultaneous control of all the major geohelminth species. New, br
oad-spectrum, low-cost anthelmintics and new understanding of epidemio
logy have led to more cost-effective and sustainable strategies. The W
HO, UNICEF and the World Bank all now support global and regional effo
rts to achieve control of morbidity from intestinal worms. In this pap
er, we aim to show what's new in clinical helminthology and what has b
rought about the great improvement in the success of the new approache
s to control.